Prevalence of the protein-energy wasting syndrome and its association with mortality in haemodialysis patients in a centre in Spain;Prevalencia del síndrome de desgaste proteico-energético y su asociación con mortalidad en pacientes en hemodiálisis en un centro en españa

Nefrologia

Volumn 33, Issue 4, 2013, Pages 495-505

  Gracia Iguacel, Carolina ^a   González Parra, Emilio ^b   Pérez Gómez, M Vanesa ^b   Mahíllo, Ignacio ^b   Egido, Jesús ^b   Ortiz, Alberto ^b   Carrero, Juan J ^c  

^a Section of Nephrology   (Spain)

^b Instituto de Investigación Sanitaria Fundación Jiménez Díaz   (Spain)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic kidney disease; Malnutrition; Mortality; Protein energy wasting; Uremic sarcopenia

Indexed keywords

ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; OUTPATIENT DEPARTMENT; PREVALENCE; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; SPAIN; WASTING SYNDROME;

AMBULATORY CARE FACILITIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; SPAIN; WASTING SYNDROME;

EID: 84882978577     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.Apr.11979     Document Type: Article

References (44)

1. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164(6):659-63.
2. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, et al. Allcause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371(9631):2173-82.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351(13):1296-305.
4. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintance hemodialysis. N Engl J Med 2002;347(25):2010-9.
5. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition- inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001;38(6):1251-63.
6. Pupim LB, Ikizler TA. Uremic malnutrition: new insights into an old problem. Semin Dial 2003;16:224-32.
7. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999;55(5):1899-911.
8. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008;73(4):391-8.
9. Gracia C. Indicadores de un nuevo concepto de malnutrición en pacientes en hemodiálisis: síndrome del gasto proteico energético (síndrome PEW, protein energy wasting). XL Congreso Nacional de la S.E.N. (2010). Abstract.
10. Leinig CE, Moraes T, Ribeiro S, Riella MC, Olandoski M, Martins C, et al. Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr 2011;21:176-83.
11. Fried L, Bernardini J, Piraino B. Comparison of the Charlson Comorbidity Index and the Davies score as a predictor of outcomes in PD patients. Perit Dial Int 2003;23:568-73.
12. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000;35(6 Suppl 2):S1-140.
13. Daugirdas JT. Second generation logarithmic estimates of single pool variable volume Kt/v. An analysis error. J Am Soc Nephrol 1993;4:1205-13.
14. Mazairac AH, de Wit GA, Grooteman MP, Penne EL, van der Weerd NC, van den Dorpel MA, et al.; CONTRAST investigators. A composite score of protein-energy nutritional status predicts mortality in haemodialysis patients no better than its individual components. Nephrol Dial Transplant 2011;26:1962-7.
15. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004;80(2):299-307.
16. Carrero JJ, Chmielewski M, Axelsson J, Snaedal S, Heimbürger O, Bárány P, et al. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr 2008;27(4):557-64.
17. Lorenzo V, de Bonis E, Hernández D, Rodríguez AP, Rufino M, González Posada J, et al. Desnutrición calórica-proteica en hemodiálisis crónica. Utilidad y limitaciones de la tasa de catabolismo proteico. Nefrologia 1994;14(Suppl 2):119-25.
18. Marcén R, Teruel JL, de la Cal MA, Gámez C. The impact of malnutrition in morbidity andmortality in stable haemodialysis patients. Nephrol Dial Transplant 1997;12(11):2324-31.
19. Marcén R, Gámez C. Estudio cooperativo de nutrición en hemodiálisis V: Tablas de parámetros antropométricos de una población en hemodiálisis. Nefrologia 1994;14(Suppl 2):60-3.
20. Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 2010;21(2):223-30.
21. Devoto G, Gallo F, Marchello C, Racchi O, Garbarini R, Bonassi S, et al. Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients. Clin Chem 2006;52(12):2281-5.
22. Foley RN, Parfrey PS, Harnett JD, Harnett JD, Kent GM, Murray DC, et al. Hypoalbumiemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 1996;7:728-36.
23. Mittman N, Avram MM, Oo KK, Hattopadhyay J. Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of prospective observation. Am J Kidney Dis 2001;38:1358-64.
24. Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA. Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 2004;66:2054-60.
25. Noori N, Kovesdy CP, Bross R, Lee M, Oreopoulos A, Benner D, et al. Novel equations to estimate lean body mass in maintenance hemodialysis patients. Am J Kidney Dis 2011;57:130-9.
26. Terrier N, Jaussent I, Dupuy AM, Morena M, Delcourt C, Chalabi L, et al. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients. Nephrol Dial Transplant 2008;23(1):345-53.
27. Espinosa Cuevas MA, Navarrete Rodriguez G, Villeda Martinez ME, Atilano Carsi X, Miranda Alatriste P, Tostado Gutiérrez T, et al. Body fluid volumen and nutritional status in hemodialysis: vector bioelectric impedance analysis. Clin Nephrol 2010;73(4):300-8.
28. Piccoli A, Pillon L, Favaro E. Asymmetry of the total body water prediction bias using the impedance index. Nutrition 1997;13:438-41.
29. Chamney PW, Kraemer M, Rode C, Kleinekofort W. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 2002;61:2250-8.
30. St-Onge MP, Wang Z, Horlick M, Wang J, Heymsfield SB. Dualenergy X-ray absorptiometry lean soft tissue hydration: independent contributions of intra- and extracellular water. Am J Physiol Endocrinol Metab 2004;287:E842-7.
31. Chamney PW, Wabel P, Moissl UM, Müller MJ, Bosy-Westphal A, Korth O, et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007;85(1): 80-9.
32. Chamney PW, Krämer M, Rode C, Kleinekofort W, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int 2002;61:2250-8.
33. Zucchelli P, Santoro A. Dry weight in hemodialysis: volemic control. Semin Nephrol 2001;21:286-90.
34. Tabei K, Nagashima H, Imura O, Sakurai T, Asano Y. An index of plasma refilling in hemodialysis patients. Nephron 1996;74:266-74.
35. Agarwal R, Light RP. Intradialytic hypertension is a marker of volume excess. Nephrol Dial Transplant 2010;25(10):3355-61.
36. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 2002;287(12):1548-55.
37. Rattanasompattikul M, Molnar MZ, Zaritsky JJ, Hatamizadeh P, Jing J, Norris KC, et al. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant 2013; in press.
38. Locatelli F, Del Vecchio L. Dialysis adequacy and response to erythropoietic agents: what is the evidence base. Nephrol Dial Transplant 2003;18 Suppl 8:viii29-35.
39. Dimkovic' N. Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency. Med Pregl 2001;54(5-6):235-40.
40. Stenvinkel P. The role of inflammation in the anaemia of end-stage renal disease. Nephrol Dial Transplant 2001;16 Suppl 7:36-40.
41. Gracia-Iguacel C, Qureshi AR, Avesani CM, Heimbürger O, Huang X, Lindholm B, et al. Subclinical versus overt obesity in dialysis patients: more than meets the eye. Nephrol Dial Transplant 2013; [in press].
42. Kalantar-Zadeh K, Streja E, Molnar MZ, Lukowsky LR, Krishnan M, Kovesdy CP, et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 2012;175:793-803.
43. Agarwal R, Bills JE, Light RP. Diagnosing obesity by body mass index in chronic kidney disease: an explanation for the "obesity paradox.". Hypertension 2010;56(5):893-900.
44. Beddhu S, Pappas LM, Ramkumar N, Samore M. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003;14:2366-72.